Skip to main content

2023 INTREPID Antiviral Summit Proceedings

The inaugural INTREPID Antiviral Summit took place in Washington, D.C., on March 22, 2023 and involved 100 pandemic preparedness thought leaders and stakeholders aiming to build on the good collaborative practices during the SARs-CoV-2 pandemic; to identify gaps in antiviral research and opportunities for the INTREPID Alliance to add value; and to foster personal interactions between thought leaders in the field.

View Full Report
Executive Summary

On March 22, 2023, 100 thought leaders convened at the inaugural INTREPID Alliance Antiviral Summit, and many made recommendations on ecosystem strengthening.

The executive summary is below and includes a list of stakeholder recommendations. The recommendations do not necessarily represent the views of the Alliance or a consensus among stakeholders.

It is imperative that we work to strengthen relationships and partnerships between the industry, government agencies, academic research organizations, philanthropies, procurement agencies, and multilateral organizations as a national and international community in order to optimize the global antiviral ecosystem for pandemic preparedness and response.

View Executive Summary and Stakeholder Recommendations
img: Quote Icon

Bridging the gap in antiviral solutions to viral pathogens with the greatest pandemic potential, requires innovation, commitment and collaboration across sectors. The INTREPID Alliance brings the experts and the platform needed to help ensure we are better prepared in the future."

James Anderson, Chair,
INTREPID Alliance; Executive Director, Global Health, IFPMA

Welcoming Remark and Opening Fireside Chat. See the Welcoming remarks by James Anderson, Chair of the IA and Ruxandra Draghia-Aklia M.D., Ph.D., Global Public Health R&D, Johnson & Johnson

And the Opening Fireside Chat WITH Susan Dentzer, President & CEO, America’s Physician Groups; Victor J. Dzau, M.D., President, U.S. National Academy of Medicine, Science & Technology Expert Group Co-Chair, and Member, International Pandemic Preparedness Secretariat Steering Group - (video) Heulwen Philpot, Head of the International Pandemic Preparedness Secretariat (IPPS) Matthew Hepburn, M.D., Senior Advisor to Director, White House Office of Science and Technology Policy (OSTP) for Pandemic Preparedness

100 Days Mission

The goal of the 100 Days Mission is to prepare as much as possible so that within the first 100 days that a pandemic threat is identified, the following interventions can be made available, safe, effective, and affordable:

  • Accurate and approved rapid point of care diagnostic tests
  • An initial regimen of therapeutics
  • Vaccines ready to be produced at scale for global - deployment
Learn More

With Thanks

Many profound thanks go to our board members, officers, moderators, speakers, Summit Organizing Commitee and over 100 attendees who participated in a robust, inspiring and solutions-oriented dialogue to begin laying out a roadmap toward the discovery, development and accessiblity of antirvirals for the next pandemic.